Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QQQ, BSX, ALNY, PODD, CVS, and represent 20.33% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: QQQ (+$48M), BIIB (+$18M), BSX (+$15M), KALV (+$13M), MCK (+$8.6M), FOLD (+$8.5M), KNSA (+$7.1M), ASMB (+$6.4M), WAY (+$6.3M), STOK (+$5.9M).
- Started 15 new stock positions in BIIB, CMPS, FDMT, BFLY, ASMB, AGIO, IMNM, MAZE, SLDB, ABVX. QQQ, STOK, TVRD, OVID, SYRE.
- Reduced shares in these 10 stocks: THC (-$19M), VRNA (-$19M), LLY (-$18M), RVTY (-$15M), IQV (-$15M), GILD (-$15M), COO (-$14M), WGS (-$14M), TVTX (-$12M), CVS (-$10M).
- Sold out of its positions in ANIP, ATYR, ARDX, GILD, NRIX, PHLT, RVTY, DGX, REPL, VRNA. ALKS, MRUS.
- Parkman Healthcare Partners was a net seller of stock by $-53M.
- Parkman Healthcare Partners has $959M in assets under management (AUM), dropping by 10.18%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 91 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 5.0 | $48M | NEW | 80k | 600.37 |
|
| Boston Scientific Corporation (BSX) | 4.4 | $42M | +53% | 434k | 97.63 |
|
| Alnylam Pharmaceuticals (ALNY) | 4.2 | $40M | -5% | 88k | 456.00 |
|
| Insulet Corporation (PODD) | 3.7 | $36M | +9% | 116k | 308.73 |
|
| CVS Caremark Corporation (CVS) | 3.0 | $29M | -26% | 380k | 75.39 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 2.7 | $26M | +37% | 672k | 38.83 |
|
| Miragen Therapeutics (VRDN) | 2.6 | $25M | -11% | 1.2M | 21.58 |
|
| Zimmer Holdings (ZBH) | 2.6 | $25M | +4% | 251k | 98.50 |
|
| Stryker Corporation (SYK) | 2.5 | $24M | +27% | 64k | 369.67 |
|
| Qiagen Nv Com Shs (QGEN) | 2.3 | $22M | 500k | 44.68 |
|
|
| McKesson Corporation (MCK) | 2.3 | $22M | +63% | 29k | 772.54 |
|
| Danaher Corporation (DHR) | 2.3 | $22M | 111k | 198.26 |
|
|
| Kalvista Pharmaceuticals (KALV) | 2.2 | $21M | +155% | 1.7M | 12.18 |
|
| Uniqure Nv SHS (QURE) | 2.1 | $20M | -22% | 345k | 58.37 |
|
| Neurocrine Biosciences (NBIX) | 2.1 | $20M | -14% | 142k | 140.38 |
|
| Biogen Idec (BIIB) | 1.9 | $18M | NEW | 130k | 140.08 |
|
| Mineralys Therapeutics (MLYS) | 1.8 | $17M | 456k | 37.92 |
|
|
| Upstream Bio (UPB) | 1.7 | $16M | +17% | 844k | 18.81 |
|
| Tenet Healthcare Corp Com New (THC) | 1.6 | $15M | -55% | 74k | 203.04 |
|
| Xeris Pharmaceuticals (XERS) | 1.5 | $15M | -14% | 1.8M | 8.14 |
|
| Livanova SHS (LIVN) | 1.5 | $14M | +57% | 276k | 52.38 |
|
| Mbx Biosciences (MBX) | 1.4 | $14M | -11% | 773k | 17.50 |
|
| Amicus Therapeutics (FOLD) | 1.4 | $13M | +177% | 1.7M | 7.88 |
|
| Doximity Cl A (DOCS) | 1.4 | $13M | +48% | 179k | 73.15 |
|
| Syndax Pharmaceuticals (SNDX) | 1.4 | $13M | -2% | 847k | 15.38 |
|
| Ptc Therapeutics I (PTCT) | 1.3 | $12M | +11% | 202k | 61.37 |
|
| Arcellx Common Stock (ACLX) | 1.3 | $12M | -14% | 150k | 82.10 |
|
| Edwards Lifesciences (EW) | 1.3 | $12M | -38% | 156k | 77.77 |
|
| Cooper Cos (COO) | 1.3 | $12M | -54% | 177k | 68.56 |
|
| Waystar Holding Corp (WAY) | 1.2 | $12M | +118% | 306k | 37.92 |
|
| Dex (DXCM) | 1.2 | $12M | -24% | 172k | 67.29 |
|
| Castle Biosciences (CSTL) | 1.1 | $11M | +35% | 476k | 22.77 |
|
| Optimizerx Corp Com New (OPRX) | 1.1 | $10M | 510k | 20.50 |
|
|
| Nuvalent Inc-a (NUVL) | 1.1 | $10M | 120k | 86.48 |
|
|
| Alphatec Hldgs Com New (ATEC) | 1.1 | $10M | +7% | 697k | 14.54 |
|
| CryoLife (AORT) | 1.0 | $9.4M | +14% | 221k | 42.34 |
|
| United Therapeutics Corporation (UTHR) | 1.0 | $9.2M | +149% | 22k | 419.21 |
|
| Axogen (AXGN) | 0.9 | $9.0M | -25% | 502k | 17.84 |
|
| Edgewise Therapeutics (EWTX) | 0.9 | $8.9M | -15% | 550k | 16.22 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $8.9M | +8% | 653k | 13.60 |
|
| Incyte Corporation (INCY) | 0.9 | $8.5M | +33% | 100k | 84.81 |
|
| Travere Therapeutics (TVTX) | 0.8 | $8.1M | -58% | 340k | 23.90 |
|
| Urogen Pharma (URGN) | 0.8 | $8.0M | +127% | 403k | 19.95 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $8.0M | -4% | 40k | 198.81 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.8 | $7.9M | -10% | 579k | 13.59 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $7.7M | 1.0M | 7.59 |
|
|
| Veracyte (VCYT) | 0.8 | $7.7M | 223k | 34.33 |
|
|
| Eli Lilly & Co. (LLY) | 0.8 | $7.6M | -69% | 10k | 763.00 |
|
| Quidel Corp (QDEL) | 0.8 | $7.4M | -34% | 253k | 29.45 |
|
| Xenon Pharmaceuticals (XENE) | 0.7 | $7.1M | +17% | 176k | 40.15 |
|
| Terns Pharmaceuticals (TERN) | 0.7 | $7.0M | +14% | 935k | 7.51 |
|
| Precigen (PGEN) | 0.7 | $6.9M | +36% | 2.1M | 3.29 |
|
| Schrodinger (SDGR) | 0.7 | $6.8M | -42% | 340k | 20.06 |
|
| BioMarin Pharmaceutical (BMRN) | 0.7 | $6.8M | -44% | 126k | 54.16 |
|
| Certara Ord (CERT) | 0.7 | $6.7M | +10% | 552k | 12.22 |
|
| Assembly Biosciences Com New (ASMB) | 0.7 | $6.4M | NEW | 251k | 25.60 |
|
| Outset Med Com New (OM) | 0.7 | $6.4M | -17% | 455k | 14.12 |
|
| Inspiremd (NSPR) | 0.6 | $5.9M | +97% | 2.4M | 2.41 |
|
| Stoke Therapeutics (STOK) | 0.6 | $5.9M | NEW | 250k | 23.50 |
|
| Iqvia Holdings (IQV) | 0.6 | $5.7M | -72% | 30k | 189.94 |
|
| Treace Med Concepts (TMCI) | 0.6 | $5.7M | 848k | 6.71 |
|
|
| Si-bone (SIBN) | 0.6 | $5.6M | +4% | 379k | 14.72 |
|
| Maze Therapeatics (MAZE) | 0.5 | $5.2M | NEW | 200k | 25.93 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.5 | $4.9M | -74% | 45k | 107.74 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $4.7M | NEW | 55k | 84.90 |
|
| Apogee Therapeutics (APGE) | 0.4 | $4.2M | +91% | 106k | 39.73 |
|
| Immunome (IMNM) | 0.4 | $4.1M | NEW | 351k | 11.71 |
|
| Protagonist Therapeutics (PTGX) | 0.4 | $4.1M | 62k | 66.43 |
|
|
| Agios Pharmaceuticals (AGIO) | 0.4 | $4.0M | NEW | 100k | 40.14 |
|
| CVRX (CVRX) | 0.4 | $4.0M | -37% | 491k | 8.07 |
|
| Mannkind Corp Com New (MNKD) | 0.4 | $3.5M | -65% | 656k | 5.37 |
|
| Rxsight (RXST) | 0.4 | $3.4M | -39% | 381k | 8.99 |
|
| Spyre Therapeutics Com New (SYRE) | 0.4 | $3.4M | NEW | 201k | 16.76 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.3 | $3.1M | 74k | 41.65 |
|
|
| Rapid Micro Biosystems Class A Com (RPID) | 0.3 | $3.1M | 913k | 3.34 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.3 | $2.8M | -16% | 97k | 29.06 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.3 | $2.7M | 271k | 9.93 |
|
|
| Tvardi Therapeutics (TVRD) | 0.3 | $2.5M | NEW | 65k | 38.97 |
|
| Solid Biosciences Com New (SLDB) | 0.3 | $2.4M | NEW | 396k | 6.17 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.2 | $2.1M | -39% | 302k | 7.05 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $2.1M | -53% | 69k | 30.08 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.2 | $1.7M | NEW | 200k | 8.69 |
|
| Quanterix Ord (QTRX) | 0.1 | $1.4M | -51% | 252k | 5.43 |
|
| Annexon (ANNX) | 0.1 | $1.2M | 406k | 3.05 |
|
|
| Butterfly Network Com Cl A (BFLY) | 0.1 | $1.2M | NEW | 602k | 1.93 |
|
| 908 Devices (MASS) | 0.1 | $879k | 100k | 8.76 |
|
|
| Pulmonx Corp (LUNG) | 0.1 | $811k | -17% | 501k | 1.62 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $573k | NEW | 100k | 5.73 |
|
| Entera Bio SHS (ENTX) | 0.1 | $539k | -21% | 281k | 1.92 |
|
| Edap Tms S A Sponsored Adr (EDAP) | 0.0 | $355k | 155k | 2.29 |
|
|
| Ovid Therapeutics (OVID) | 0.0 | $264k | NEW | 203k | 1.30 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2025 Q3 filed Nov. 14, 2025
- Parkman Healthcare Partners 2025 Q2 filed Aug. 14, 2025
- Parkman Healthcare Partners 2025 Q1 filed May 15, 2025
- Parkman Healthcare Partners 2024 Q4 filed Feb. 14, 2025
- Parkman Healthcare Partners 2024 Q3 filed Nov. 14, 2024
- Parkman Healthcare Partners 2024 Q2 filed Aug. 14, 2024
- Parkman Healthcare Partners 2024 Q1 filed May 15, 2024
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022
- Parkman Healthcare Partners 2021 Q4 filed Feb. 11, 2022
- Parkman Healthcare Partners 2021 Q3 filed Nov. 12, 2021